Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03621098 · ClinicalTrials.gov registry record
EMPOWER-PULM (PULMonary Outcomes in Older Adults Empowered With Movement to Prevent Obesity and Weight Regain)
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 76
- Enrollment target
NCT03621098 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 76 participants.
The verdict
NCT03621098 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
Study Summary
The purpose of this study is to improve the understanding of the effects of weight loss on the lungs in older adults. Different types of tests to understand the effects of the EMPOWER interventions on lung function will be administered.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2016-12-15 |
| Est. Completion | 2018-11-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03621098
The ClinicalTrials.gov registry entry for NCT03621098 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03621098 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03621098 about?
NCT03621098 is a clinical study titled "EMPOWER-PULM (PULMonary Outcomes in Older Adults Empowered With Movement to Prevent Obesity and Weight Regain)". The purpose of this study is to improve the understanding of the effects of weight loss on the lungs in older adults. Different types of tests to understand the effects of the EMPOWER interventions on lung function will be administered.
What is the current status of trial NCT03621098?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2016-12-15. Estimated completion is 2018-11-19.
Who is sponsoring clinical trial NCT03621098?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.